Press Releases

Sep
23
2022

Visit Aktiedagen Lund September 26, and learn how ultrasound can be used to fight the world’s deadliest diseases

Monday September 26, 6.30-7.00 pm (18:30-19:00) Elite Hotel Ideon, Scheelevägen 27 At Aktiedagen Lund on Monday 26 September 2022, AcouSort’s Commercial Director Agnes Michanek will talk about how AcouSort’s unique

Read More
Sep
9
2022

AcouSort selected by EIC for participation at MEDICA, Europe’s leading medical exhibition

AcouSort has been selected by the European Innovation Council (EIC) for participation at MEDICA 2022 after a highly competitive evaluation process. AcouSort is thus one of the 20 companies selected

Read More
Aug
24
2022

AcouSort Interim report Q2, 2022

Regulatory

Today, August 24, 2022, AcouSort is releasing its Interim Report for Q2, 2022. The report is available both in Swedish and English and can be found here Interim Report Q2

Read More
Aug
13
2022

The European Innovation Council (EIC) awards the AcouSort project AcouSome SEK 26 million to develop groundbreaking technology for exosome-based diagnostics

Exosomes are nanoparticles that enable human cells to communicate vital information with each other. They have potential to open a completely new field within diagnostics, as they can give us

Read More
Aug
10
2022

AcouSort significantly strengthens its commercial capabilities with the recruitments of Kelley Intehar and Agnes Michanek

AcouSort is rapidly moving towards full commercialization of its solutions for point-of-care diagnostics. In parallel, the company sees a rapidly increasing interest for its technology within precision medicine. With the

Read More
Aug
8
2022

AcouSort’s and Werfen’s joint patent application has received national approval in the US

AcouSort AB (publ) (“AcouSort”, the “Company”) today announces that the Company’s and its partner Werfen’s (“Werfen”) (formerly Instrumentation Laboratory Company) U.S. patent application received national approval in the United States

Read More
Jun
9
2022

AcouSort: Scientific progress with AcouWash enables new method for cancer treatment monitoring

AcouSort’s first AcouWash customer, the prestigious US National Institute of Health (NIH), has published a scientific paper demonstrating the use of the system in a cancer treatment monitoring method. The

Read More
May
18
2022

AcouSort Interim Report Q1 2022

Regulatory

Today, May 18, 2022, AcouSort is releasing its Interim Report for Q1, 2022. The report is in both Swedish and English. Read the full report here.

Read More
May
11
2022

AcouSort sells AcouWash system to Pharmacolog

AcouSort has sold an AcouWash system to Uppsala-based Pharmacolog AB. The deal has its origins in the Letter of Intent that the companies announced in May 2021 and follows a

Read More
May
9
2022

AcouSort selected by EIC for participation in leading medical exhibition

AcouSort has been selected by the European Innovation Council (EIC) for participation in the European Pavilion at BIO2022 after a highly competitive evaluation process. AcouSort is thus one of 20

Read More